Moderna receives FDA approval for lower-dose COVID-19 vaccine, mNexspike, with restrictions on who can receive it.

By Nina Agrawal Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines against Covid-19. Scientists with funding from the National Institutes of Health were ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

The success of these COVID-19 vaccines is remarkable and was far from guaranteed. mRNA is incredibly delicate. Enzymes in the environment and in our bodies are quick to chop mRNA into pieces ...

Ribosomes, often referred to as the cell’s protein factories, translate messenger RNA (mRNA) into a specific sequence of amino acids, in a process referred to as translation. During this process, the ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer thought of Moderna, Inc. (NASDAQ ...

How to contact Nature Biotechnology executives were elated. Trump had, just five years earlier, propelled mRNA medicines into the spotlight through his signature effort to fast-track the ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

That’s why a bill introduced last month at the Minnesota Legislature, HF 3219 — which attempts to label mRNA technology as a “biological weapon” — isn’t just misguided. It’s dangerous.

The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease.